Consolidated Statements of Operations (USD $)	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Product sales, net	$ 4,677	$ 5,563
Product royalties-related party, net	10,272
Total Revenues	14,949	5,563
COST OF SALES	3,337	6,601
GROSS MARGIN	11,612	(1,038)
Research and development	104,413	313,671
Depreciation and amortization	692	1,227
Professional fees	3,159,015	935,912
General and administrative	458,136	492,815
Total Operating Expenses	3,722,256	1,743,625
OPERATING LOSS	(3,710,644)	(1,744,663)
Patent licensing income	138,577	136,128
Gain on settlement of debt	27,422
Loss on equity investment		(8,508)
Interest expense	(225)
Other income		12,420
Total Other Income (Expense)	165,774	140,040
Loss before income taxes and noncontrolling interest	(3,544,870)	(1,604,623)
NET INCOME (LOSS)	(3,544,870)	(1,604,623)
Less: Net loss attributable to noncontrolling interest	(53,191)	(77,205)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	(3,491,679)	(1,527,418)
Foreign currency translation adjustments	(17,580)	131,198
Total Other Comprehensive Income (Loss)	(17,580)	131,198
COMPREHENSIVE LOSS	$ (3,562,450)	$ (1,473,425)
BASIC AND DILUTED LOSS PER SHARE	$ 0	$ 0
BASIC AND DILUTED WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	116,691,252	93,923,235